This document is a publication of a European patent application (EP4630120A1) from the EPO Bulletin, specifically concerning solid state forms of the drug Zipalertinib and the process for its preparation. The application was filed by Assia Chemical Industries Ltd. and lists three inventors. This publication represents a new patent application being made public, not a final grant or a rule change.

As this is a patent application publication, there are no immediate compliance obligations for regulated entities. However, companies involved in pharmaceutical development, particularly those working with kinase inhibitors or similar oncology drugs, should be aware of this filing as it pertains to intellectual property in the field. Further monitoring of the patent's prosecution and potential grant would be advisable for competitive intelligence.